Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DME62OQ)

• Drug Name: 5-oxo-1-2-4-oxadiazol biphenyl Drug Info
• Synonyms: compound 1c [PMID: 22410249]

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 136218976
  TTD Drug ID: DME62OQ

Molecule-Related Drug Atlas

Drug(s) Targeting Angiotensin II receptor type-1 (AGTR1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Losartan	DM72JXH	Diabetic kidney disease	GB61.Z	Approved	[2]
Olmesartan medoxomil	DMWBHRY	High blood pressure	BA00	Approved	[3]
Irbesartan	DMTP1DC	Diabetic kidney disease	GB61.Z	Approved	[2]
Valsartan	DMREUQ6	Chronic heart failure	BD1Z	Approved	[2]
Candesartan	DMRK8OT	Chronic heart failure	BD1Z	Approved	[4]
Telmisartan	DMS3GX2	Hypertension	BA00-BA04	Approved	[5]
ANGIOTENSIN II	DMLWQ27	Increase blood pressure	BA04	Approved	[6]
SARALASIN	DMKS1DV	Hypertension	BA00-BA04	Approved	[7]
Tasosartan	DMM13DI	Hypertension	BA00-BA04	Approved	[8]
Eprosartan	DM07K2I	Hypertension	BA00-BA04	Approved	[9]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Angiotensin II receptor type-1 (AGTR1)	TT8DBY3	AGTR1_HUMAN	Antagonist	[1]

References

• [1] Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect. Bioorg Med Chem. 2012 Apr 15;20(8):2747-61.
• [2] Radioligand binding assays: application of [(125)I]angiotensin II receptor binding. Methods Mol Biol. 2009;552:131-41.
• [3] Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers. J Cardiovasc Pharmacol. 2009 Jul;54(1):47-56.
• [4] Candesartan: widening indications for this angiotensin II receptor blocker Expert Opin Pharmacother. 2009 Aug;10(12):1995-2007.
• [5] Deletion of angiotensin II type I receptor reduces hepatic steatosis. J Hepatol. 2009 Jun;50(6):1226-35.
• [6] The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. J Med Chem. 2010 Mar 11;53(5):2063-75.
• [7] Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. J Med Chem. 2008 Jul 24;51(14):4150-69.
• [8] Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding. J Pharmacol Exp Ther. 2000 Nov;295(2):649-54.
• [9] Clinical profile of eprosartan: a different angiotensin II receptor blocker. Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):253-7.